Publication:
Pubertal and gonadal outcomes in 46,XY individuals with partial androgen insensitivity syndrome raised as girls

dc.contributor.authorGÜRAN, TÜLAY
dc.contributor.authorsGuaragna-Filho G., Guerra-Junior G., Tadokoro-Cuccaro R., Hughes I. A., Barros B. A., Hiort O., Balsamo A., GÜRAN T., Holterhus P. M., Hannema S., et al.
dc.date.accessioned2023-04-03T10:27:25Z
dc.date.accessioned2026-01-11T19:03:01Z
dc.date.available2023-04-03T10:27:25Z
dc.date.issued2023-03-01
dc.description.abstractIntroduction: Although it was common in the 1970s-1990s to assign female gender of rearing to 46,XY infants with limited virilization of varying etiologies, including those with partial androgen insensitivity syndrome (PAIS), long-term data on outcomes for these individuals are sparse. Therefore, our goal was to use the power of an international registry to evaluate clinical features, surgical management, and pubertal data in patients with a molecularly confirmed diagnosis of PAIS who were born before 2008 and were raised as girls. Methods: The current study interrogated the International Disorders of Sex Development Registry for available data on management and pubertal outcomes in individuals with genetically confirmed PAIS who were raised as girls. Results: Among the 11 individuals who fulfilled the key criteria for inclusion, the external masculinization score (EMS) at presentation ranged from 2 to 6 (median 5); 7 girls underwent gonadectomy before the age of 9 years, whereas 4 underwent gonadectomy in the teenage years (>= age 13). Clitoral enlargement at puberty was reported for 3 girls (27%) who presented initially at the time of puberty with intact gonads. In the 9 individuals (82%) for whom gonadal pathology data were provided, there was no evidence of germ cell tumor at median age of 8.1 years. All girls received estrogen replacement, and 8/11 had attained Tanner stage 4-5 breast development at the last assessment. Conclusion: In general, although it appears that female assignment in PAIS is becoming uncommon, our data provide no evidence to support the practice of prophylactic prepubertal gonadectomy with respect to the risk of a germ cell tumor.
dc.identifier.citationGuaragna-Filho G., Guerra-Junior G., Tadokoro-Cuccaro R., Hughes I. A., Barros B. A., Hiort O., Balsamo A., GÜRAN T., Holterhus P. M., Hannema S., et al., "Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls", SEXUAL DEVELOPMENT, 2023
dc.identifier.doi10.1159/000526997
dc.identifier.issn1661-5425
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/36917969/
dc.identifier.urihttps://hdl.handle.net/11424/288104
dc.language.isoeng
dc.relation.ispartofSEXUAL DEVELOPMENT
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectMikrobiyal Genetik
dc.subjectTemel Bilimler
dc.subjectLife Sciences
dc.subjectMolecular Biology and Genetics
dc.subjectMicrobial Genetics
dc.subjectNatural Sciences
dc.subjectGELİŞİMSEL BİYOLOJİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectDEVELOPMENTAL BIOLOGY
dc.subjectMOLECULAR BIOLOGY & GENETICS
dc.subjectLife Sciences (LIFE)
dc.subjectEmbriyoloji
dc.subjectMoleküler Biyoloji
dc.subjectGelişimsel Biyoloji
dc.subjectSağlık Bilimleri
dc.subjectEmbryology
dc.subjectMolecular Biology
dc.subjectDevelopmental Biology
dc.subjectHealth Sciences
dc.subjectPuberty
dc.subjectAndrogen insensitivity syndrome
dc.subjectPartial androgen insensitivity syndrome
dc.subjectDisorders of sex development
dc.subjectDifferences of sex development
dc.subjectRECEPTOR GENE-MUTATIONS
dc.subjectGERM-CELL TUMORS
dc.subjectCONSENSUS STATEMENT
dc.subjectSEX
dc.subjectDISORDERS
dc.subjectFERTILITY
dc.subjectPATIENT
dc.subjectGONADECTOMY
dc.subjectMANAGEMENT
dc.subjectPHENOTYPE
dc.titlePubertal and gonadal outcomes in 46,XY individuals with partial androgen insensitivity syndrome raised as girls
dc.typearticle
dspace.entity.typePublication

Files